◆ TICKERBASEVista interactiva →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Inicio › Todas las acciones › 4536 · English version

Santen Pharmaceutical Co., Ltd. (4536)

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-10-02

Santen Pharmaceutical Co., Ltd. engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally. The company operates through Medical drugs, Over-the-counter drugs, Medical equipment, and others segments.

Cifras clave

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados2026-03-312025-03-312024-03-312023-03-31
Ingresos totalesJPY 291.6BJPY 300.0BJPY 302.0BJPY 279.0B
Beneficio brutoJPY 169.7BJPY 171.0BJPY 178.7BJPY 166.1B
Ingresos operativos (EBIT)JPY 47.8BJPY 46.9BJPY 38.5B(JPY 3.1B)
Ingresos netosJPY 37.4BJPY 36.3BJPY 26.6B(JPY 14.9B)

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 4536. /companies/us/4536

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.